secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Therapeutics, Inc. (—)
CIK:        0001404935
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001477932-25-004827
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

THC Therapeutics acquires The Headquarters Group in ~$11M all-stock deal
------------------------------------------------------------------------

- Acquired 100% of THG for 11,007 shares of new Series D Preferred stock, valued at ~$11M.
- THG subsidiaries include Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, and real estate; combined 2024 revenue ~$4.8M.
- Management cites 60+ years combined experience; plans vertical integration for growth in CA/OR cannabis markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225004827/0001477932-25-004827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404935/000147793225004827/thct_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-004827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer